At 9.0% CAGR, the Middle East & Africa Poultry Diagnostic Market is Projected to be Worth US$ 22.91 million by 2030, Says Business Market Insights

According to Business Market Insights research, the Middle East & Africa poultry diagnostic market was valued at US$ 11.53 million in 2022 and is expected to reach US$ 22.91 million by 2030, registering a CAGR of 9.0% from 2022 to 2030. Rising zoonotic disease cases and technological advancements attributed to the Middle East & Africa poultry diagnostic market expansion.   

Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team in Philippines successfully developed a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.

On the contrary, insufficient welfare measures for poultry hampers the Middle East & Africa poultry diagnostic market.

Based on test type, the Middle East & Africa poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held 43.3% share of Middle East & Africa poultry diagnostic market in 2022, amassing US$ 4.99 million. It is projected to garner US$ 10.34 million by 2030 to expand at 9.5% CAGR during 2022–2030.

In terms of disease, the Middle East & Africa poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian mycoplasmosis segment held 29.9% share of Middle East & Africa poultry diagnostic market in 2022, amassing US$ 3.45 million. It is projected to garner US$ 6.88 million by 2030 to expand at 9.0% CAGR during 2022–2030.

By country, the Middle East & Africa poultry diagnostic market has been categorized into the South Africa, Saudi Arabia, UAE, and the Rest of MEA. Our regional analysis states that South Africa captured 71.9% share of Middle East & Africa poultry diagnostic market in 2022. It was assessed at US$ 8.30 million in 2022 and is likely to hit US$ 16.88 million by 2030, exhibiting a CAGR of 9.3% during 2022–2030.  

Key players operating the Middle East & Africa poultry diagnostic market are Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Boehringer Ingelheim International GmbH, Zoetis Inc, and BioCheck BV Biotechnologies, among others.

• May-2023: Idexx Laboratories Inc announced partnership with Haychem that specialized in the development, manufacturing, and distribution of veterinary diagnostic products and services. The partnership aims to expand the product offerings in Bangladesh for IDEXX and increase veterinary vaccinations and diagnostics.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com